Establishment of the Human Intestinal and Salivary Microbiota Biobank - Oncologic Diseases

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

July 11, 2022

Study Completion Date

July 11, 2022

Conditions
Non Small Cell Lung CancerMetastatic Melanoma
Interventions
OTHER

Biological sample collection

Collection of faeces, coproculture examination, urine, saliva, PBMC and blood for biobanking, to evaluate the proteomic, metascriptomic, metabolomic, metagenomic, and metagenetic profile, and to perform routine screening. Analysis for the identification, quantification and characterization of health-promoting bacteria

OTHER

Questionnaire

Anamnestic questionnaire, 3-day food questionnaire, Food Frequency Questionnaire

OTHER

Medical examination

Blood pressure measurement, abdominal and thoracic physical examination

Trial Locations (1)

Unknown

IRCCS Istituto Tumori Giovanni Paolo II, Bari

All Listed Sponsors
collaborator

Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies

OTHER

collaborator

Istituti Tumori Giovanni Paolo II

NETWORK

collaborator

University of Bari Aldo Moro

OTHER

collaborator

University of Salento

OTHER

lead

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

OTHER

NCT04698161 - Establishment of the Human Intestinal and Salivary Microbiota Biobank - Oncologic Diseases | Biotech Hunter | Biotech Hunter